Coronavirus Essential podcast | Phase 3 trials for India's Covaxin to start next month; USFDA approves Remdesivir as the first COVID-19 treatment drug

Tune in to Coronavirus Essential with Sakshi Batra for all the latest news on the pandemic.

Moneycontrol News

October 23, 2020 / 19:38 IST

On October 22, Bharat Biotech's coronavirus vaccine Covaxin received approval for carrying out Phase III trials. Reports suggested that the trials may begin next month.

Meanwhile, the US Food and Drug Administration gave its final nod to Gilead's antiviral drug Remdesivir for treating hospitalised Covid-19 patients.

Tune in to Coronavirus Essential with Sakshi Batra for all the latest news on the pandemic.

Moneycontrol News

first published: Oct 23, 2020 07:38 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347